Contact Us

Winners of Prestigious ‘Innovation of the Year’ Award 2025 Cambridge Independent

cover-business-awards-2025

Winners of Prestigious ‘Innovation of the Year’ Award 2025 Cambridge Independent

CAMBRIDGE, UK – September 27, 2025 – Upfront Diagnostics, today announced it has been honoured with the Innovation of the Year award at the 2025 Cambridge Independent Business Awards. The highly coveted award recognises the company’s groundbreaking advancements in diagnostic technology and its potential to significantly impact patient care globally.

The award was presented at a ceremony celebrating the region’s most successful and innovative businesses, acknowledging Upfront Diagnostics’ dedication to developing rapid, accurate, and accessible diagnostic tools. The recognition underscores the company’s success in bringing a disruptive technology to market that addresses critical unmet needs in the healthcare sector.

“We are deeply honoured and thrilled to receive the Innovation of the Year award from the Cambridge Independent,” said Gonzalo Ladreda, CEO of Upfront Diagnostics. “This accolade is a testament to the hard work, dedication, and ingenuity of our entire team. It validates our mission to put better, faster diagnostics Upfront—where they can make the biggest difference in treatment outcomes and patient lives. Cambridge is a hub for world-class innovation, and to be recognised here at our home is truly special.”

The Cambridge Independent Business Awards celebrate organisations driving economic growth and setting new standards for excellence. Upfront Diagnostics was selected by the judging panel for the novelty and transformative potential of its core technology. The company intends to use this momentum to accelerate the deployment of its innovative platform, ensuring its benefits reach healthcare providers and patients worldwide.

About UpFront Diagnostics

Founded in Cambridge, UK, in 2017, UpFront Diagnostics is a MedTech company pioneering point-of-care diagnostics for critical, time-sensitive conditions. The company’s lead product, LVOne, is designed to revolutionise emergency stroke care by providing immediate, actionable diagnostic information. UpFront Diagnostics is committed to transforming patient outcomes by solving the current triage gap in stroke pathways.

Recent Posts

patient care

Innovation Must Begin and End with the Patient

Every year on World Stroke Day, the global medical community rallies around a stark, unavoidable rea
Read More
Upfront_World_Stroke_Day

9 Years, One Biomarker Panel, and a Vision for Equitable Stroke Care

On World Stroke Day, the global medical community unites to address one of healthcare’s most time-
Read More
BE-16x9-26-S46

Upfront diagnostics named to the 2026 BE100

We’re grateful to be recognised among the 2026 BE100—and deeply thankful to the committed team w
Read More